Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Nimesulide→

Nimesulide Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
51803-78-2
Molecular formula
C13H12N2O5S
Molecular weight
308.31 g/mol
Drug class
Non-steroidal anti-inflammatory drug (NSAID)relatively COX-2-selective sulfonanilide
Mechanism of action
Inhibits cyclo-oxygenase enzymes, with relative preference for COX-2, reducing prostaglandin synthesis involved in pain, inflammation and fever.
Indications / reported uses
  • Short-term treatment of acute pain and primary dysmenorrhoea in countries where nimesulide remains authorised; osteoarthritis use is subject to local product restrictions.

Sources: https://pubchem.ncbi.nlm.nih.gov/compound/4495 · https://www.ncbi.nlm.nih.gov/books/NBK547948/

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Nimesulide Environmental Risk Assessment (ERA) (the Nimesulide ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.